Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Hepatology ; 2024 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-38441908

RESUMO

BACKGROUND AND AIMS: Alcohol relapse after surviving an episode of alcohol-associated hepatitis (AH) is common. However, the clinical features, risk factors, and prognostic implications of recurrent alcohol-associated hepatitis (RAH) are not well described. APPROACH AND RESULTS: A registry-based study was done of patients admitted to 28 Spanish hospitals for an episode of AH between 2014 and 2021. Baseline demographics and laboratory variables were collected. Risk factors for RAH were investigated using Cox regression analysis. We analyzed the severity of the index episodes of AH and compared it to that of RAH. Long-term survival was assessed by Kaplan-Meier curves and log-rank tests. A total of 1118 patients were included in the analysis, 125 (11%) of whom developed RAH during follow-up (median: 17 [7-36] months). The incidence of RAH in patients resuming alcohol use was 22%. The median time to recurrence was 14 (8-29) months. Patients with RAH had more psychiatric comorbidities. Risk factors for developing RAH included age <50 years, alcohol use >10 U/d, and history of liver decompensation. RAH was clinically more severe compared to the first AH (higher MELD, more frequent ACLF, and HE). Moreover, alcohol abstinence during follow-up was less common after RAH (18% vs. 45%, p <0.001). Most importantly, long-term mortality was higher in patients who developed RAH (39% vs. 21%, p = 0.026), and presenting with RAH independently predicted high mortality (HR: 1.55 [1.11-2.18]). CONCLUSIONS: RAH is common and has a more aggressive clinical course, including increased mortality. Patients surviving an episode of AH should undergo intense alcohol use disorder therapy to prevent RAH.

2.
Front Chem ; 11: 1128859, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36778030

RESUMO

SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. For the virus to enter the host cell, its spike (S) protein binds to the ACE2 receptor, and the transmembrane protease serine 2 (TMPRSS2) cleaves the binding for the fusion. As part of the research on COVID-19 treatments, several Casiopeina-analogs presented here were looked at as TMPRSS2 inhibitors. Using the DFT and conceptual-DFT methods, it was found that the global reactivity indices of the optimized molecular structures of the inhibitors could be used to predict their pharmacological activity. In addition, molecular docking programs (AutoDock4, Molegro Virtual Docker, and GOLD) were used to find the best potential inhibitors by looking at how they interact with key amino acid residues (His296, Asp 345, and Ser441) in the catalytic triad. The results show that in many cases, at least one of the amino acids in the triad is involved in the interaction. In the best cases, Asp435 interacts with the terminal nitrogen atoms of the side chains in a similar way to inhibitors such as nafamostat, camostat, and gabexate. Since the copper compounds localize just above the catalytic triad, they could stop substrates from getting into it. The binding energies are in the range of other synthetic drugs already on the market. Because serine protease could be an excellent target to stop the virus from getting inside the cell, the analyzed complexes are an excellent place to start looking for new drugs to treat COVID-19.

3.
Gastroenterol Hepatol ; 46(4): 282-287, 2023 Apr.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-35964809

RESUMO

BACKGROUND AND AIMS: The diagnostic and therapeutic strategy in severe lower gastrointestinal bleeding (LGIB) varies depending on the patient's clinical situation. Actual clinical practice guidelines propose different management strategies. We aim to know the attitude of the gastroenterologists from different hospitalary centers in the management of this entity. METHODS: Descriptive and observational study using an on-line questionnaire, addressed to gastroenterologists in Spain and Latin America, in December 2021. RESULTS: We included 281 anonymous questionnaires of gastroenterologists from Spain and Latin America. Diagnostic and therapeutic management of severe LGIB was heterogeneous among the participants. Regarding to the first diagnostic modalities they showed variability between performing computed tomography angiography (CTA) (44.5%), gastroscopy (33.1%), colonoscopy (20.6%) and arteriography (1.1%). The therapeutic attitude after a positive CTA mostly varied between performing arteriography (38.1%) and colonoscopy (44.1%). If negative CTA, in the majority of cases a gastroscopy was performed. If the patient needed intensive critical unit (ICU) care and to undergo colonoscopy, most participants performed an urgent colonoscopy (<24h) (31% always, 43.4% in most cases); while if the patient did not require ICU admission this percentage was lower (10% always, 33.8% in most cases). The 40.9% of the participants admitted having doubts about the management of this patients and the 98.2% considered the need for a creation of an action protocol. CONCLUSIONS: There is a high interhospitalary variability on the management of severe lower gastrointestinal bleeding among gastroenterologists. It is necessary to unify the diagnostic and therapeutic management of this pathology.


Assuntos
Colonoscopia , Hospitalização , Humanos , Colonoscopia/métodos , Angiografia por Tomografia Computadorizada , Tomografia Computadorizada por Raios X , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/etiologia , Hemorragia Gastrointestinal/terapia
6.
Gastroenterol. hepatol. (Ed. impr.) ; 33(1): 17-20, ener. 2010.
Artigo em Espanhol | IBECS | ID: ibc-80374

RESUMO

La enfermedad celíaca se caracteriza por el daño de la mucosa intestinal y la consiguiente malabsorción de nutrientes en individuos genéticamente predispuestos tras la ingesta de gluten. Es una enfermedad compleja, resultado de la interacción de un componente genético poligénico y varios factores ambientales. Se ha propuesto la teoría de que procesos infecciosos transitorios o aumentos en la permeabilidad de la barrera mucosa podrían facilitar el inicio de la enfermedad por los péptidos del gluten de la luz intestinal. Presentamos el caso de 2 pacientes que presentaron el inicio de la enfermedad tras la curación de una hepatitis aguda por virus de la hepatitis B. Se discute la fisiopatología de la enfermedad y se plantean hipótesis que expliquen esta asociación (AU)


Celiac disease is characterized by small intestinal mucosal injury and nutrient malabsorption in genetically susceptible individuals following dietary ingestion of gluten. The pathogenesis of the disease involves interactions between environmental, genetic, and immunologic factors. Transient infections or increased permeability of the mucosa may facilitate disease onset induced by the uptake of gluten peptides into a microenvironmental milieu in the small intestinal mucosa. We present two patients with onset of celiac disease after resolution of acute hepatitis B virus infection. The physiopathology of celiac disease is discussed and possible explanations for this association are proposed (AU)


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Doença Celíaca/etiologia , Hepatite B/complicações , Doença Aguda , Doença Celíaca/diagnóstico
7.
Gastroenterol Hepatol ; 33(1): 17-20, 2010 Jan.
Artigo em Espanhol | MEDLINE | ID: mdl-19744748

RESUMO

Celiac disease is characterized by small intestinal mucosal injury and nutrient malabsorption in genetically susceptible individuals following dietary ingestion of gluten. The pathogenesis of the disease involves interactions between environmental, genetic, and immunologic factors. Transient infections or increased permeability of the mucosa may facilitate disease onset induced by the uptake of gluten peptides into a microenvironmental milieu in the small intestinal mucosa. We present two patients with onset of celiac disease after resolution of acute hepatitis B virus infection. The physiopathology of celiac disease is discussed and possible explanations for this association are proposed.


Assuntos
Doença Celíaca/etiologia , Hepatite B/complicações , Doença Aguda , Doença Celíaca/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade
8.
Gastroenterol. hepatol. (Ed. impr.) ; 32(10): 693-696, dic. 2009. ilus
Artigo em Espanhol | IBECS | ID: ibc-85458

RESUMO

El carcinoma escamoso del páncreas es un tumor extraordinariamente infrecuente.Caso clínicoPaciente varón de 63 años que acude a la consulta del gastroenterólogo por un cuadro constitucional acompañado del hallazgo de una masa pétrea supraclavicular izquierda. El escáner demostró la existencia de una neoplasia de cuerpo pancreático que interesaba tronco celíaco. La histología de la adenopatía supraclavicular y del páncreas fue de carcinoma epidermoide queratinizante.ConclusionesEn el artículo se realiza una revisión sobre la incidencia, las características de este tumor tan infrecuente y las nuevas indicaciones de tratamiento (AU)


Squamous carcinoma of the pancreas is a highly uncommon tumor.Case reportA 63-year-old man was referred to the gastroenterology department because of hyporexia, cachexia and weight loss. A left supraclavicular node was noted. The computed tomography scan showed a tumor in the pancreatic body involving the celiac axis. Histological examination of the supraclavicular node and pancreatic mass revealed squamous cell carcinoma.ConclusionsThe incidence and characteristics of this highly infrequent tumor, as well as new treatment indications, are reviewed (AU)


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Carcinoma de Células Escamosas/diagnóstico , Neoplasias Pancreáticas/diagnóstico , Metástase Linfática , Biópsia , Tomografia Computadorizada por Raios X
10.
Gastroenterol Hepatol ; 32(10): 693-6, 2009 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-19748706

RESUMO

UNLABELLED: Squamous carcinoma of the pancreas is a highly uncommon tumor. CASE REPORT: A 63-year-old man was referred to the gastroenterology department because of hyporexia, cachexia and weight loss. A left supraclavicular node was noted. The computed tomography scan showed a tumor in the pancreatic body involving the celiac axis. Histological examination of the supraclavicular node and pancreatic mass revealed squamous cell carcinoma. CONCLUSIONS: The incidence and characteristics of this highly infrequent tumor, as well as new treatment indications, are reviewed.


Assuntos
Carcinoma de Células Escamosas/secundário , Metástase Linfática , Neoplasias Pancreáticas/diagnóstico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Biomarcadores Tumorais/sangue , Carcinoma de Células Escamosas/sangue , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/radioterapia , Cisplatino/administração & dosagem , Terapia Combinada , Desoxicitidina/administração & dosagem , Desoxicitidina/análogos & derivados , Fluoruracila/administração & dosagem , Humanos , Neoplasias Hepáticas/secundário , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica , Cuidados Paliativos , Neoplasias Pancreáticas/sangue , Neoplasias Pancreáticas/diagnóstico por imagem , Neoplasias Pancreáticas/tratamento farmacológico , Radiografia , Neoplasias da Coluna Vertebral/diagnóstico por imagem , Neoplasias da Coluna Vertebral/radioterapia , Neoplasias da Coluna Vertebral/secundário , Vimblastina/administração & dosagem , Vimblastina/análogos & derivados , Vinorelbina , Gencitabina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...